AzTrials
AzTrials

Adolescent Behavior DisorderCARMENNCT05820581

Characterization of Mentalization Profiles Related to Emotional Regulation Among Teenagers With Behavioral Disorders

A study testing Mentalisation in people with Adolescent Behavior Disorder and Eye Movements, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Behavioral disorders in adolescents are defined by a set of diverse behaviors (such as aggressiveness, agitation, clastic crisis, running away and endangerment) whose common characteristic is the predominance of action/ mentalization. Read more about this study

Who is it for?
Ages 12 to 18 years
Conditions the study is for
Adolescent Behavior Disorder, Eye Movements
What is being tested?
Mentalisation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
65 participants
Where
1 siteFrance
Study dates
26 Jun 2023to Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Teenage girls or boys aged 12 to 17
  • Adolescent(s) with externalized behavioral disorder(s):
  • running away, suicide attempts, self-aggression (scarification, self-mutilation), taking drugs, hetero-aggressive behavior, theft, conduct disorders sexual, oppositional behavior, lies, clastic anger.
  • Non-objection of the adolescent to participate in the study.
  • Written consent of the two holders of parental authority

Who cannot join

  • Intellectually disabled
  • Autism Spectrum Disorder
  • Psychotic disorder

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • CHU de Besançon

    Besançon

    Monika Szymanska, 00000000, mszymanska@chu-besancon.fr

    Recruiting

Other trials in France

About this study

Behavioral disorders in adolescents are defined by a set of diverse behaviors (such as aggressiveness, agitation, clastic crisis, running away and endangerment) whose common characteristic is the predominance of action/ mentalization. These disorders are associated with significant morbidity and high mortality linked to a high rate of suicide or attempted suicide. Behavioral disorders are also associated with an alteration of mentalizing capacities, that is the psychic process by which the adolescent imagines and interprets his behavior and that of others on the basis of mental states such as needs, desires, beliefs or feelings. The disorders are also associated with emotional dysregulation. To date, the psychopathological processes underlying behavioral disorders in adolescents are unknown and prevent from offering appropriate psychological care. Thus, it seems essential to characterize this clinical population by integrating both its intrapsychic representations and the physiological parameters of emotional regulation associated with it.

This project is a first step towards a larger-scale research project aimed at evaluating treatment by TBM (therapies based on mentalization) in adolescents with behavioral disorders.

Read the detailed description

Behavioral disorders in adolescents are defined by a set of behaviors (such as aggressiveness, agitation, clastic crisis, running away and endangerment) whose common characteristic is the predominance of action over mentalization and opposition to normal socialization processes.

These disorders are associated with significant morbidity and high mortality linked to a high rate suicide or attempted suicide. Behavioral disorders in adolescence are linked to defects of mentalization (i.e. the psychic process by which the adolescent imagines and interprets his behaviors and to alterations in emotional regulation capacities. This emotional dysregulation has several components, including motor and physiological components. Moreover, this dysregulation is constructed in a dynamic process linked to the environment, including the adolescent's relationship with parents. To date, the psychopathological processes underlying behavioral disorders in the teenager are unknown, which prevents from offering appropriate psychological care. Thus, it seems essential to characterize adolescents behavior, by integrating both mentalizing capacities, the physiological parameters of their emotional regulation and the interactive patterns with their parents. This approach allow to overcome the difficulty of adolescents to use words to express what they feel and thus to understand their psychic functioning and the strategies, which they put in place to regulate their emotions.

This study is a monocentric cross-sectional descriptive observational study.

Objectives of this study is to describe the mentalization profiles of adolescents with mental disorders behavior and to evaluate:

  • Oculomotor parameters of emotional regulation
  • Physiological parameters of emotional regulation (Electrodermal Activity, RED)
  • Self-assessed mentalizing abilities (RFQ-Y scale)
  • Emotional regulation (DERS scale)
  • The emotional and behavioral functioning of adolescents (YSR scale)
  • Attachment characteristics of adolescents (ARSQ scale)
  • The interactions of the adolescent with his parent (GPACS scale)
  • Parental reflexive capacities (RFQ scale). This research was developed to support a comprehensive understanding of adolescent processes with the integration of bio-neuro-social parameters.

The aim of this study is to establish mentalization profiles of the clinical population of adolescents with behavioral disorders and their neurophysiological correlates of emotional regulation.

These first data are essential for a better understanding of this clinical population and a starting point for future research; particularly to develop therapies based on mentalization in this population and to evaluate their effectiveness.

Being tested
Mentalisation
Keywords
Mentalisation, Emotion regulation, Adolescents, Neurophysiological parameters
Medical subject headings
Emotional Regulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MentalisationBehavioural

    Hypomentalisation, hypermentalisation, correct mentalisation, lack of mentalisation

Study groups in NCT05820581
Study groupRoleWhat they receive
MentalisationExperimental4 mentalisation groups will be defined: hypomentalisation, hypermentalisation, mentalisation correct and lack of mentalisation
Receives: Behavioral: Mentalisation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. eye fixation duration evaluated with eyes tracker

    fixation duration (time in millisecond)

    Measured: 12 months

  2. eye dwell time evaluated with eyes tracker

    dwell time (time in millisecond)

    Measured: 12 months

  3. eye fixation count evaluated with eyes tracker

    fixation count ( time in millisecond)

    Measured: 12 months

Secondary outcomes (7)
  1. MASC Score

    Mentalization score

    Measured: 12 months

  2. YSR score

    youth self report score

    Measured: 12 months

  3. RFQ-Y score

    Reflective Function Questionnaire for Youth

    Measured: 12 months

  4. DERS score

    Difficulties in Emotion Regulation Scale (DERS)

    Measured: 12 months

  5. ARSQ score

    Adolescent relationship scale questionnaire

    Measured: 12 months

  6. parent's RFQ score

    Reflective Functioning Questionnaire for parents

    Measured: 12 months

  7. GPACS interaction evaluation

    General Practitioner Attitudes and Confidence Scale is a tool to measure confidence and attitude.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2023
  2. Study start26 Jun 2023
  3. Primary completionJun 2026 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
65 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05820581
Sponsor's protocol ID
2021/646
Acronym
CARMEN
Status last verified
Sep 2024
First submitted
27 Mar 2023
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Szymanska M, Monnin J, Tio G, Vidal C, Girard F, Galdon L, Smith CC, Bifulco A, Nezelof S, Vulliez-Coady L. How do adolescents regulate distress according to attachment style? A combined eye-tracking and neurophysiological approach. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:39-47. doi: 10.1016/j.pnpbp.2018.08.019. Epub 2018 Aug 27.

    PubMed 30165119
  • Taubner S, Volkert J, Gablonski TC, Rossouw T. [Mentalization-Based Treatment for Adolescents with Borderline Personality Disorder - Concept and Efficacy]. Prax Kinderpsychol Kinderpsychiatr. 2017 Jul;66(6):423-434. doi: 10.13109/prkk.2017.66.6.423. German.

    PubMed 28701091
  • Sharp C, Pane H, Ha C, Venta A, Patel AB, Sturek J, Fonagy P. Theory of mind and emotion regulation difficulties in adolescents with borderline traits. J Am Acad Child Adolesc Psychiatry. 2011 Jun;50(6):563-573.e1. doi: 10.1016/j.jaac.2011.01.017. Epub 2011 Mar 9.

    PubMed 21621140
  • Sharp C, Ha C, Carbone C, Kim S, Perry K, Williams L, Fonagy P. Hypermentalizing in adolescent inpatients: treatment effects and association with borderline traits. J Pers Disord. 2013 Feb;27(1):3-18. doi: 10.1521/pedi.2013.27.1.3.

    PubMed 23342954
  • Quek J, Bennett C, Melvin GA, Saeedi N, Gordon MS, Newman LK. An investigation of the mentalization-based model of borderline pathology in adolescents. Compr Psychiatry. 2018 Jul;84:87-94. doi: 10.1016/j.comppsych.2018.04.005. Epub 2018 Apr 14.

    PubMed 29727808

Questions about this trial

What is this clinical trial studying?

A study testing Mentalisation in people with Adolescent Behavior Disorder and Eye Movements, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lauriane Vulliez, PR ((0033)0381218154, lvulliez@chu-besancon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

eye fixation duration evaluated with eyes tracker (time frame: 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05820581, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in